Slide 1: Dexcom earnings Q1 2026
bpexcom Dexcom earnings Q1 2026
Slide 2: Safe harbor statement
Safe harbor statement This presentation contains “forward - looking statements” that are based on our management’s beliefs and assumptions and on inform ation available to management as of April 30, 2026. We intend for such forward - looking statements to be covered by the safe harbor provisions for
Slide 3: First quarter 2026
First quarter 2026 Key Financial Strategic $1.192 billion in revenue Highlights Highlights 12% organic revenue 1 growth over Q1’25 Generated over $400M in free Expanded the launch of Dexcom G7 (11% US; 17% INT’L2) cash flow in Q1’26 15 Day across all channels in the US Showcased extensive clinical e
Slide 4: First quarter performance
First quarter performance Total Revenue & Organic Growth Rate* 1 Non - GAAP Gross Profit and Margin* ($MM) ($MM) $1,500 $1,209 $1,260 $900 $741 $800 $1,157 $1,192 $696 $757 $1,200 $1,036 $750 $596 $900 $600 $450 $600 $300 $300 +14% +15% +20% +12% +12% $150 57.5% 60.1% 61.3% 63.5% 63.5% $0 $0 Q1'25 Q
Slide 5: 2026 Guidance as of April 30, 2026
2026 Guidance as of April 30, 2026 2026 Annual Revenue and Profitability Guidance Non - GAAP Non - GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin* 1 Objectives & considerations • Gross margin expansion: USD – Improved freight Previous 5.16 – 5.25 and manufacturing ~63 – 6
Slide 6: Appendix
Appendix Revenue Data and GAAP Reconciliations
Slide 7: Itemized Reconciliation between GAAP and Financial Measures
DexCom, Inc. Itemized Reconciliation between GAAP and Non - GAAP Financial Measures Three Months Ended March 31, Three Months Ended March 31, (In millions) 2026 2025 (In millions, except per share data) 2026 2025 GAAP gross profit $ 750.3 $ 589.0 GAAP net income $ 199.5 $ 105.4 Amortization of intan
Slide 8: Trended Quarterly and Annual Revenue Metrics by Geography
DexCom , Inc. Trended Unaudited Quarterly and Annual Revenue Related Metrics by Geography Total Company 2023 – 2026 YTD Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Revenue Metrics By Geography US Revenue (millions) $ 526.0 $ 616.6 $ 713.6 $ 769.1 $ 653.2 $ 731.9 $ 7
Slide 9: Trended Quarterly and Annual Organic Revenue Metrics
DexCom , Inc. Trended Unaudited Quarterly and Annual Organic Revenue Metrics Total Company 2023 – 2026 YTD Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 (1) Organic Revenue INT'L Revenue - Reported $ 215.5 $ 254.7 $ 261.4 $ 265.4 $ 267.8 $ 272.4 $ 292.3 $ 310.7 $ 285.
Slide 10: Definitions related to Financial Measures
DexCom, Inc. Definitions related to Non - GAAP Financial Measures Amortization of intangible assets – We are required under GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful lives. We exclude these non - cash amortization c